MX9603359A - 2-heteroaril-5,11-dihidro-6h-dipirido[3,2-b:2',3'-e][1-4]-di azepinas y su uso en la prevencion o el tratamiento de infeccion por hiv. - Google Patents

2-heteroaril-5,11-dihidro-6h-dipirido[3,2-b:2',3'-e][1-4]-di azepinas y su uso en la prevencion o el tratamiento de infeccion por hiv.

Info

Publication number
MX9603359A
MX9603359A MX9603359A MX9603359A MX9603359A MX 9603359 A MX9603359 A MX 9603359A MX 9603359 A MX9603359 A MX 9603359A MX 9603359 A MX9603359 A MX 9603359A MX 9603359 A MX9603359 A MX 9603359A
Authority
MX
Mexico
Prior art keywords
zepines
dipyrido
dia
dihydro
heteroaryl
Prior art date
Application number
MX9603359A
Other languages
English (en)
Other versions
MXPA96003359A (es
Inventor
Karl D Hargrave
Terence A Kelly
Suresh R Kapadia
John R Proudfoot
Daniel W Mcneil
Usha R Patel
Mario G Cardozo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MX9603359A publication Critical patent/MX9603359A/es
Publication of MXPA96003359A publication Critical patent/MXPA96003359A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describieron 2-hetoroaril-5,11-dihidro-6H-dipirido[3,2-b:2',3'- e][1,4]diazepinas. Esta son utiles en la prevencion o en el tratamiento de una infeccion por VIH-1.
MXPA/A/1996/003359A 1994-02-18 1995-02-17 2-heteroaril-5,11-dihidro-6h-dipirido[3,2-b:2',3'-e][1-4]-diazepinas y su uso en la prevencion o eltratamiento de infeccion de vih MXPA96003359A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US19824294A 1994-02-18 1994-02-18
US198,242 1994-02-18
US35641594A 1994-12-14 1994-12-14
US356415 1994-12-14
US356,415 1994-12-14
US198242 2002-07-18

Publications (2)

Publication Number Publication Date
MX9603359A true MX9603359A (es) 1998-07-31
MXPA96003359A MXPA96003359A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
DE69502587D1 (de) 1998-06-25
KR970701190A (ko) 1997-03-17
DK0745083T3 (da) 1999-01-25
JPH09509179A (ja) 1997-09-16
TW327171B (en) 1998-02-21
DE69502587T2 (de) 1998-11-26
CN1138861A (zh) 1996-12-25
CN1043347C (zh) 1999-05-12
AU1845795A (en) 1995-09-04
ATE166353T1 (de) 1998-06-15
AU690646B2 (en) 1998-04-30
CA2183571A1 (en) 1995-08-24
EP0745083A1 (en) 1996-12-04
WO1995022545A1 (en) 1995-08-24
CO4340691A1 (es) 1996-07-30
EP0745083B1 (en) 1998-05-20
PL181323B1 (pl) 2001-07-31
RU2142464C1 (ru) 1999-12-10
PL316006A1 (en) 1996-12-23
ES2118575T3 (es) 1998-09-16

Similar Documents

Publication Publication Date Title
IL110340A0 (en) Spiro compounds containing five-membered rings
CA2192255A1 (en) Treatment of chlamydia infectious diseases by rifamycin derivative
PL316006A1 (en) 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b',3'-e][1,4] diazepines and their application in preventing and treating hiv infections
CA2082629A1 (en) Novel method for preparing 3-amino-2-chloro-4-alkylpyridines
CA2014771A1 (en) 5,11-dihydro-6h-dipyrido[3,2-b:2'3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
HUT64027A (en) Process for producing 4-alkyl-3-amino-2-chloropyridines
WO1988000587A3 (en) 5-HETERO- OR ARYL-SUBSTITUTED-IMIDAZO[2,1-a]ISOQUINOLINES
TW357140B (en) Substituted benzenesulfonylureas and -thioureas having cardiac activity, processes for their preparation, and the pharmaceutical compositions thereof
DK0598396T3 (da) Forbedret fremgangsmåde til fremstilling af 3-amino-2-chlor-4-alkylpyridiner
NZ333587A (en) Topiramate derivatives useful in treating psoriasis
CA2228393A1 (en) Use of adamantane derivatives for treating diseases of the inner ear